During the past decade, Lotus Clinical Research conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 33 clinical trials were completed, i.e. on average, 62.3% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 17 clinical trials were completed. i.e. 77.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lotus Clinical Research" #1 sponsor was "Lotus Clinical Research, LLC" with 6 trials, followed by "Pacira Pharmaceuticals, Inc" with 5 trials sponsored, "AcelRx Pharmaceuticals, Inc." with 4 trials sponsored, "Baudax Bio" with 4 trials sponsored and "Concentric Analgesics" with 4 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lotus Clinical Research" #1 collaborator was "CerSci Therapeutics" with 2 trials as a collaborator, "Lotus Clinical Research, LLC" with 2 trials as a collaborator, "Mallinckrodt" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Nevakar Injectables, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Lotus Clinical Research" are "Acute Pain" (10 trials), "Pain" (6 trials), "Pain, Postoperative" (5 trials), "Postoperative Pain" (5 trials) and "Abdominoplasty" (4 trials). Many other conditions were trialed in "Lotus Clinical Research" in a lesser frequency.

Most popular intervention types in "Lotus Clinical Research" are "Drug" (63 trials), "Device" (8 trials), "Other" (4 trials), "Biological" (2 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Bupivacaine Hydrochloride" (6 trials), "Acetaminophen" (4 trials), "Bupivacaine HCl" (3 trials) and "CA-008" (3 trials). Other intervention names were less common.

The vast majority of trials in "Lotus Clinical Research" are 67 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Lotus Clinical Research". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 51 completed trials in Lotus Clinical Research, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Lotus Clinical Research, 8 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".